Prognostic factors for the course of functional status of patients with ALS: a systematic review
暂无分享,去创建一个
Frans Nollet | Anita Beelen | L. H. van den Berg | A. Beelen | F. Nollet | Leonard H. van den Berg | H. Grupstra | Huub Creemers | Hepke Grupstra | H. Creemers
[1] A. Chiò,et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[2] A. L. La Spada,et al. ALS motor phenotype heterogeneity, focality, and spread , 2009, Neurology.
[3] M. Swash,et al. Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.
[4] C. Lengeler,et al. Language bias in randomised controlled trials published in English and German , 1997, The Lancet.
[5] The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. , 1996, Archives of neurology.
[6] D. Levy,et al. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[7] Robert H. Brown,et al. Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[8] Maurizio Fava,et al. Amyotrophic lateral sclerosis disease progression model , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[9] D. Moher,et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews , 1996, The Lancet.
[10] Craig K. Enders,et al. The influence of personality factors on disease progression and health‐related quality of life in people with ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[11] O. Hardiman,et al. Cognitive changes predict functional decline in ALS , 2013, Neurology.
[12] B. Mohammadi,et al. ALSFRS-R score and its ratio: A useful predictor for ALS-progression , 2008, Journal of the Neurological Sciences.
[13] S. Paganoni,et al. Uric acid levels predict survival in men with amyotrophic lateral sclerosis , 2012, Journal of Neurology.
[14] Lucette Lacomblez,et al. Progression in ALS is not linear but is curvilinear , 2010, Journal of Neurology.
[15] Matthew C Kiernan,et al. Biomarkers in amyotrophic lateral sclerosis , 2009, The Lancet Neurology.
[16] M. Swash,et al. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis? , 2006, Archives of neurology.
[17] J. Broach,et al. Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research , 2014, Muscle & nerve.
[18] E. Steyerberg,et al. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research , 2013, PLoS medicine.
[19] A. Chiò,et al. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[20] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[21] G. Logroscino,et al. Natural history of upper motor neuron-dominant ALS , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[22] E. Beghi,et al. Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[23] M. Kiernan,et al. Development of a model to guide decision making in amyotrophic lateral sclerosis multidisciplinary care , 2015, Health expectations : an international journal of public participation in health care and health policy.
[24] S. Petri,et al. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis , 2013, European journal of neurology.
[25] G. Guyatt,et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.
[26] O. Hardiman,et al. Amyotrophic lateral sclerosis , 2011, The Lancet.
[27] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[28] A. Forbes,et al. Clinical phenotypes and natural progression for motor neuron disease: Analysis from an Australian database , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[29] Douglas G Altman,et al. Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.
[30] Howard Balshem,et al. GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.
[31] Robert H. Brown,et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[32] M. Sabatelli,et al. Uncovering amyotrophic lateral sclerosis phenotypes: Clinical features and long-term follow-up of upper motor neuron-dominant ALS , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[33] Alan Tennant,et al. The use of raw scores from ordinal scales: time to end malpractice? , 2012, Journal of rehabilitation medicine.
[34] Daniel Stahl,et al. Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups , 2009, PloS one.
[35] K. Kaiboriboon,et al. A role for functional classification in the early identification of prognostic factors in ALS , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[36] C. Bombardier,et al. Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.
[37] L. Goldstein,et al. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment , 2013, The Lancet Neurology.
[38] F. Khan,et al. Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. , 2009, The Cochrane database of systematic reviews.
[39] L. Ouchchane,et al. Rates of progression of weight and forced vital capacity as relevant measurement to adapt Amyotrophic Lateral Sclerosis management for patient Result of a French multicentre cohort survey , 2013, Journal of the Neurological Sciences.
[40] A. Voustianiouk,et al. ALSFRS and appel ALS scores: Discordance with disease progression , 2008, Muscle & nerve.
[41] A. Al-Chalabi,et al. A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.
[42] Jill Hayden,et al. Evaluation of the Quality of Prognosis Studies in Systematic Reviews , 2006, Annals of Internal Medicine.